![Philip C. Bird](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philip C.
Bird currently works as a Director, Director-Clinical Studies & CMO at Porosome Therapeutics, Inc.
| Sociétés | Poste | Début |
|---|---|---|
Viron Therapeutics Holdings, Inc.
 Viron Therapeutics Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in drug development and manufacturing of type 1 & type 2 diabetic therapeutics | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 1 |
|---|---|
Viron Therapeutics Holdings, Inc.
Viron Therapeutics Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in drug development and manufacturing of type 1 & type 2 diabetic therapeutics | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
